Insulin-like growth factors (IGFs) and IGF-binding proteins in active monitoring of localized prostate cancer: a population-based observational study

Changes in PSA kinetics predict metastasis-free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents

(2011) Emmanuel S. Antonarakis et al.   CANCER

Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer

(2011) Mari-Anne Rowlands et al.   CANCER CAUSES & CONTROL

Circulating Insulin-Like Growth Factors and IGF-Binding Proteins in PSA-Detected Prostate Cancer: The Large Case-Control Study ProtecT

(2011) M.-A. Rowlands et al.   CANCER RESEARCH

Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies

(2010) J.A. Lane et al.   EUROPEAN JOURNAL OF CANCER

Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively

(2010) M. Frank O'Brien et al.   INTERNATIONAL JOURNAL OF CANCER

Prostate-Specific Antigen Kinetics During Follow-Up Are an Unreliable Trigger for Intervention in a Prostate Cancer Surveillance Program

(2010) Ashley E. Ross et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival

(2009) Mattias Johansson et al.   PROSTATE

Prostate-Specific Antigen Kinetics in Clinical Decision-Making During Active Surveillance for Early Prostate Cancer—A Review

(2008) Roderick C.N. van den Bergh et al.   EUROPEAN UROLOGY